Swiss National Bank Quotient LTD Transaction History

Swiss National Bank

$150 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 08, 2022	SELL	$1.89 - $3.12 $316,008 - $521,664	-167,200 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$3.48 - $4.45 $60,552 - $77,430	-17,400 Reduced 9.43%	167,200 $609,000
Q1 2021 May 07, 2021	BUY	$3.57 - $6.2 $24,276 - $42,160	6,800 Added 3.82%	184,600 $679,000
Q4 2020 Feb 05, 2021	BUY	$4.4 - $7.32 $10,120 - $16,836	2,300 Added 1.31%	177,800 $926,000
Q3 2020 Nov 09, 2020	BUY	$4.38 - $8.35 $179,580 - $342,350	41,000 Added 30.48%	175,500 $902,000
Q2 2020 Aug 05, 2020	SELL	$3.64 - $9.26 $19,656 - $50,004	-5,400 Reduced 3.86%	134,500 $995,000
Q1 2020 May 08, 2020	BUY	$2.54 - $9.38 $12,954 - $47,838	5,100 Added 3.78%	139,900 $553,000
Q4 2019 Feb 06, 2020	BUY	$7.07 - $9.51 $250,278 - $336,654	35,400 Added 35.61%	134,800 $1.28 Million
Q3 2019 Nov 12, 2019	BUY	$7.77 - $11.26 $20,202 - $29,276	2,600 Added 2.69%	99,400 $772,000
Q2 2019 Aug 02, 2019	BUY	$7.91 - $10.25 $765,688 - $992,200	96,800 New	96,800 $905,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.